Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 5, 2004 - Issue 2
Submit an article Journal homepage
28
Views
8
CrossRef citations to date
0
Altmetric
Review

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

David P Nicolau Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour St, Box 5037, Hartford, CT 06102-5037, USA. [email protected]
Pages 229-235 | Published online: 02 Mar 2005

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carman A. Ciervo & Jun Shi. (2005) Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections. Current Medical Research and Opinion 21:10, pages 1641-1650.
Read now

Articles from other publishers (7)

Elena De Vecchi, Lucia Nicola, Monica Larosa & Lorenzo Drago. (2008) In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations. BMC Microbiology 8:1.
Crossref
Steven D Brown. (2008) Benefit-Risk Assessment of Telithromycin in the Treatment of Community-Acquired Pneumonia. Drug Safety 31:7, pages 561-575.
Crossref
Stephen G. Jenkins. (2006) In vitro susceptibility testing for the new ketolide antibacterial telithromycin — influence of methodologic factors. Clinical Microbiology Newsletter 28:18, pages 137-142.
Crossref
Stephen Douthwaite, Jari Jalava & Lene Jakobsen. (2005) Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm . Molecular Microbiology 58:2, pages 613-622.
Crossref
Megan Nguyen & Eunice P. Chung. (2005) Telithromycin: The first ketolide antimicrobial. Clinical Therapeutics 27:8, pages 1144-1163.
Crossref
George G. Zhanel, Christel Johanson, Nancy Laing, Tamiko Hisanaga, Aleksandra Wierzbowski & Daryl J. Hoban. (2005) Pharmacodynamic Activity of Telithromycin at Simulated Clinically Achievable Free-Drug Concentrations in Serum and Epithelial Lining Fluid against Efflux ( mefE )-Producing Macrolide- Resistant Streptococcus pneumoniae for Which Telithromycin MICs Vary . Antimicrobial Agents and Chemotherapy 49:5, pages 1943-1948.
Crossref
George G. Zhanel, Christel Johanson, Tamiko Hisanaga, Chris Mendoza, Nancy Laing, Ayman Noreddin, Aleksandra Wierzbowski & Daryl J. Hoban. (2004) Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations. Journal of Antimicrobial Chemotherapy 54:6, pages 1072-1077.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.